GlassScriptPhysician profile
Stacey Ratliff
NPI 1942716758
$2,195.00
in general payments reported to CMS, 2019-2025
33 companies · $856 in 2025
The $856 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $39.30 · 2023: $52.20 · 2024: $932 · 2025: $856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,840.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $441.17 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $379.30 | 2024-2025 | Veozah |
| Abbvie INC. | $339.01 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.90 | 2021-2024 | Trintellix |
| Astrazeneca Pharmaceuticals LP | $75.23 | 2025 | Airsupra, Breztri |
| Antares Pharma, INC. | $63.76 | 2021-2022 | |
| Boston Scientific Corporation | $55.04 | 2024-2025 | Bodyguardian, Watchman Access System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.01 | 2024-2025 | Xifaxan, Trulance |
| Otsuka America Pharmaceutical, INC. | $51.16 | 2024-2025 | Rexulti |
| Pfizer INC. | $47.88 | 2024-2025 | |
| Hologic Sales and Service, LLC | $39.71 | 2021-2025 | Aptima, Thinprep 2000 Processor |
| Esperion Therapeutics, INC. | $39.62 | 2024-2025 | Nexletol |
| Edwards Lifesciences Corporation | $39.25 | 2025 | Sapien 3 Ultra Resilia |
| Mayne Pharma Commercial LLC | $36.21 | 2024 | |
| Amarin Pharma, INC. | $35.19 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $34.12 | 2024 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.40 | 2024-2025 | Jardiance |
| Biohaven Pharmaceuticals, INC. | $33.20 | 2021 | |
| Phathom Pharmaceuticals, INC. | $32.40 | 2024-2025 | Voquezna |
| Dexcom, INC. | $30.68 | 2022-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $29.52 | 2021-2024 | Otezla, Repatha |
| Qol Medical, LLC | $26.85 | 2025 | Sucraid |
| Sumitomo Pharma America, INC. | $25.14 | 2024 | Myfembree |
| Millicent US INC | $24.08 | 2025 | Intrarosa |
| Exact Sciences Corporation | $23.94 | 2024 | Cologuard Collection Kit |
| Regeneron Healthcare Solutions, INC. | $19.97 | 2024 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $19.50 | 2025 | |
| Azurity Pharmaceuticals, INC. | $18.02 | 2023 | Adthyza |
| Shield Therapeutics INC | $16.83 | 2024 | |
| Alexion Pharmaceuticals, INC. | $15.33 | 2025 | Strensiq |
| Teva Pharmaceuticals USA, INC. | $14.56 | 2024 | Ajovy |
| Daiichi Sankyo INC. | $12.78 | 2021 | |
| Lilly USA, LLC | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Ratliff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.